Maverick Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Maverick Therapeutics's estimated annual revenue is currently $620k per year.(i)
  • Maverick Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Maverick Therapeutics has 4 Employees.(i)
  • Maverick Therapeutics grew their employee count by -67% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$1.1M70%N/AN/A
#4
$2.3M15150%N/AN/A
#5
$1.4M90%N/AN/A
#6
$11.5M74-12%N/AN/A
#7
$0.4M27510%$236.7MN/A
#8
$4M51-74%$160MN/A
#9
$2.5M1633%N/AN/A
#10
$3.3M21-12%N/AN/A
Add Company

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Maverick's highly innovative platform, COBRAâ„¢, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.

keywords:N/A

N/A

Total Funding

4

Number of Employees

$620k

Revenue (est)

-67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Maverick Therapeutics News

2022-04-13 - Eyes on the prize: Aurion Biotech raises $120M for 'global ...

In early studies of two therapies presented at the annual meeting of ... Bristol Myers Squibb, Merck and Maverick Therapeutics—the latter...

2022-04-13 - AACR: By microdosing tumors, Takeda and Presage examine how ...

Takeda hopes these therapies could help make tumors more receptive to other ... Merck and Maverick Therapeutics—the latter two announced alongside a $13...

2022-04-06 - HIV drug stabilizes disease progression in metastatic colorectal cancer

DPR is a consultant/advisory board member for MPM Capital, Gritstone Oncology, Oncorus, Maverick Therapeutics, 28/7 Therapeutics,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.3M4N/AN/A
#2
$0.3M4N/AN/A
#3
$0.4M4-43%N/A
#4
$0.3M4N/AN/A
#5
$0.3M4N/AN/A